# OnCo record orphan-drug-act (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/orphan-drug-act/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "orphan-drug-act" ;
  schema:name "Orphan Drug Act 1983"@en ;
  schema:alternateName "Orphan Drug Act of 1983"@en, "ODA 1983"@en, "orphan drug exclusivity"@en, "seven-year orphan exclusivity"@en, "orphan drug tax credit"@en ;
  schema:description "The 1983 US law that pays companies to develop drugs for rare diseases with seven years of market exclusivity, tax credits and fee waivers, which is why so many cancer drugs are first approved for a rare subtype."@en ;
  schema:url <https://onco.cc/terms/orphan-drug-act/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Orphan_Drug_Act_of_1983> ;
  schema:citation <https://en.wikipedia.org/wiki/Orphan_Drug_Act_of_1983>, <https://www.fda.gov/industry/designating-orphan-product-drugs-and-biological-products/orphan-drug-act-relevant-excerpts>, <https://www.fda.gov/industry/medical-products-rare-diseases-and-conditions/designating-orphan-product-drugs-and-biological-products> ;
  onco:tag "law", "us" ;
  onco:related <https://onco.cc/terms/orphan-designation/>, <https://onco.cc/terms/orphan-drug/>, <https://onco.cc/terms/eu-orphan-regulation/>, <https://onco.cc/terms/us-regulatory-exclusivity/>, <https://onco.cc/terms/inflation-reduction-act/>, <https://onco.cc/terms/rare-cancers/>, <https://onco.cc/terms/bpca-prea/>, <https://onco.cc/terms/hatch-waxman/> ;
  onco:institutions <https://onco.cc/institutions/fda-oce/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-rare-cancers/>, <https://onco.cc/bottlenecks/b-incentive-misalignment/>, <https://onco.cc/bottlenecks/b-drug-pricing/> .